{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-016726","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2021-07-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.325141+00:00","generated_at":"2026-06-30T06:17:42.183823+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"LeMaitre Vascular increases CEO annual equity to $1.1M, raises executive salaries for 2022","bullets":["CEO annual equity value increased from $725k to $1.1M; other NEOs: Pellegrino $250k->$500k, Roberts $250k->$500k, Kamke $115k->$225k.","2022 cash compensation approved: CEO salary rises to $568,498 (from $473,470) with bonus target $333,880; similar increases for other NEOs.","New equity grants will be 50% stock options, 25% RSUs, and 25% performance stock units.","Compensation Committee adopted Eighth Amended and Restated Equity Award Grant Policy formalizing grant process and levels."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-016726","json":"https://secwatch.observer/filing/0001437749-21-016726.json","markdown":"https://secwatch.observer/filing/0001437749-21-016726.md","text":"https://secwatch.observer/filing/0001437749-21-016726.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000143774921016726/0001437749-21-016726-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000143774921016726/lmat20210708_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T06:17:42.183823+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}